| | Prepare for hyperopic shift following DSAEK graft surgery
| | A retrospective study including 45 eyes that underwent Descemet?s stripping automated endothelial keratoplasty (DSAEK) found an average refractive change of +0.88 D after surgery. That hyperopic shift after DSAEK has implications for management of patients undergoing cataract surgery simultaneously with or after DSAEK and for anticipating refractive outcomes in pseudophakic patients undergoing DSAEK. | |  |
|
|
| Vaccines may have future in ocular HZV and HPV
| | Ophthalmology Times | | Vaccines may have a role in corneal and external ocular disease, specifically for herpes zoster virus and human papilloma virus infections, because of the successes of the vaccines in preventing systemic diseases. |
| | Optical coherence tomography a useful addition to clinical practice, doctor finds
| Noncontact device does not require pupil dilation, although learning curve is associated with its use
| | Ophthalmology Times | | A proprietary device for optical coherence tomography (Visante, Carl Zeiss Meditec) seems to be a highly useful addition to clinical practice. The instrument, according to one physician, may be the best resource thus far to evaluate placement of intracorneal segments, femtosecond laser-enabled keratoplasty, and penetrating keratoplasty. |
|
| Riboflavin and UV treatment promotes collagen cross-linking in patients with ectasia
| Combination may be beneficial in biomechanical stabilization
| | Ophthalmology Times | | The combination of ultraviolet radiation and riboflavin treatment to achieve collagen cross-linking may be beneficial in biomechanical stabilization of ectasia, according to an expert who says the combined procedure has reduced the need for penetrating keratoplasty in his practice by 70%. |
| | Oral treatment options abound for dry eye
| Medical history, nutrition, other causes play important role in determining best therapy
| | Ophthalmology Times | | The eyes can be affected by over-the-counter (OTC) systemic medications, nutrition habits, and systemic agents—all of which contribute to dry eye. Oral treatment options should be considered in these cases, whereas topical treatment with artificial tears is the best option for external causes. |
| | Artificial tear delivers high-performance dry eye therapy
| | Ophthalmology Times | | A new high-performance artificial tear product (Systane Ultra, Alcon Laboratories) was created with an intelligent delivery system designed to maximize comfort upon instillation and provide sustained symptomatic relief and ocular surface protection. |
|
| | TB4 can protect cornea against oxidative damage
| | Ophthalmology Times | | Administering TB4 (Thymosin Beta 4, RegeneRx) up-regulates anti-oxidative enzymes in human corneal epithelial cells, helping to protect the cornea and resist oxidative damage, according to researchers. |
| | UV rays don't just damage skin
| | Ophthalmology Times | | Prevent Blindness has dedicated May as UV Awareness Month in an effort to educate the public on the best way to protect their eyes. |
| | | Corneal implants okayed for use in Canada
| | Ophthalmology Times | | Addition Technology has received regulatory clearance from Health Canada to market its corneal implants (Intacs) for keratoconus and myopia indications. |
|
| 
